Phibro Animal Health Corporation PAHC
Set alert
38.74 USD -0.14 -0.36%
At close · Nov 2
38.74 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
38.06 Day range 40.53
28.25 52-week range 60.08
- YTD
- +3.69%
- 1 year
- -7.89%
- Open
- 39.41
- Prev close
- 38.88
- Mkt cap
- 1.57B
- Vol
- 250.44K
- Avg vol
- 219.91K
- EPS
- 2.43
- P/E
- 15.94
- Div yield
- 1.24%
More statistics
- Low
- 38.06
- High
- 40.53
- Forward P/E
- 10.07
- Beta
- 0.40
- Short ratio
- 4.10
- Inst. own
- 102.94%
- Dividend
- 0.48
- Ex-div date
- Sep 1, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 36.99
- 200-d avg
- 41.26
- 1y target
- 47.00
Analyst view
Consensus: none
Price target (mean) 47.00 +21.3% upside
Now 38.74
- Target (low)
- 37.00
- Target (mean)
- 47.00
- Target (high)
- 55.00
Ratings (0m) 3 1 buy · 2 hold · 0 sell
- Strong buy1
- Buy0
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 4
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.78267 | 0.76 – 0.80801 | 0.73 | +7.2% | 383.00M | +5.3% | 3 |
| Next quarter | 0.93968 | 0.90936 – 0.97 | 0.87 | +8.0% | 393.00M | +5.1% | 2 |
| Current year | 3.50 | 3.48 – 3.51 | 3.22 | +8.6% | 1.58B | +3.9% | 3 |
| Next year | 3.85 | 3.68 – 4.10 | 3.50 | +10.1% | 1.63B | +3.5% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 14, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Apr 15, 2026 | Citigroup | Initiated | — | Neutral |
| Nov 7, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 29, 2025 | B of A Securities | Maintained | Underperform | Underperform |
| Jul 7, 2025 | JP Morgan | Upgrade | Neutral | Overweight |
| Jun 25, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Feb 10, 2025 | Barclays | Maintained | Underweight | Underweight |
| Dec 17, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 12, 2024 | Barclays | Maintained | Underweight | Underweight |
| Sep 10, 2024 | JP Morgan | Initiated | — | Neutral |
| Aug 30, 2024 | B of A Securities | Maintained | Underperform | Underperform |
| May 10, 2024 | Barclays | Maintained | Underweight | Underweight |
| Nov 9, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 1, 2023 | Roth MKM | Reiterated | Buy | Buy |
| Aug 31, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 29, 2023 | Roth MKM | Reiterated | Buy | Buy |
| Jul 27, 2023 | Morgan Stanley | Reiterated | Equal-Weight | Equal-Weight |
| May 4, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Feb 9, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Dec 21, 2022 | Roth Capital | Initiated | — | Buy |
| Nov 10, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Sep 16, 2022 | Barclays | Maintained | — | Underweight |
| Aug 26, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jul 25, 2022 | Barclays | Downgrade | Equal-Weight | Underweight |
| Jan 10, 2022 | Barclays | Upgrade | Underweight | Equal-Weight |
| Nov 18, 2021 | Morgan Stanley | Initiated | — | Equal-Weight |
| Jul 7, 2021 | Barclays | Downgrade | Equal-Weight | Underweight |
| May 13, 2021 | Morgan Stanley | Maintained | — | Underweight |
| May 8, 2020 | Credit Suisse | Maintained | — | Neutral |
